Pierre H Mangin Selected Research

Thrombosis (Thrombus)

11/2023	Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy.
10/2023	Mice expressing nonpolymerizable fibrinogen have reduced arterial and venous thrombosis with preserved hemostasis.
7/2023	The relative importance of platelet integrins in hemostasis, thrombosis and beyond.
6/2023	Conservative versus aggressive antiplatelet strategy for emergent carotid stenting during stroke thrombectomy.
2/2023	Comparison of three antithrombotic strategies for emergent carotid stenting during stroke thrombectomy: a multicenter study.
1/2023	Glycoprotein VI interplay with fibrin(ogen) in thrombosis.
5/2022	Characterization of the Role of Integrin α5β1 in Platelet Function, Hemostasis, and Experimental Thrombosis.
7/2021	Respective roles of Glycoprotein VI and FcγRIIA in the regulation of αIIbβ3-mediated platelet activation to fibrinogen, thrombus buildup, and stability.
1/2021	In vitro flow-based assay: From simple toward more sophisticated models for mimicking hemostasis and thrombosis.
1/2021	Differential Role of Glycoprotein VI in Mouse and Human Thrombus Progression and Stability.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre H Mangin Research Topics

Disease

23	Thrombosis (Thrombus) 11/2023 - 06/2013
5	Hemorrhage 11/2023 - 07/2013
4	Neoplasms (Cancer) 05/2024 - 09/2017
4	Atherosclerotic Plaque (Atheroma) 11/2023 - 01/2011
3	Neoplasm Metastasis (Metastasis) 05/2024 - 09/2017
3	Vascular System Injuries 01/2021 - 07/2015
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2023 - 01/2021
2	Stroke (Strokes) 06/2023 - 02/2023
2	Inflammation (Inflammations) 09/2017 - 09/2017
1	ST Elevation Myocardial Infarction 11/2023
1	Acute Coronary Syndrome 11/2023
1	Transfusion Reaction 10/2023
1	Sepsis (Septicemia) 07/2023
1	Cerebral Infarction 02/2023
1	COVID-19 01/2023
1	Pneumonia (Pneumonitis) 05/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Hemolysis 01/2020
1	Rupture 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2017
1	Dehydration (Water Stress) 09/2015
1	Thrombocytosis (Thrombocythemia) 02/2015
1	Atherosclerosis 01/2011

Drug/Important Bio-Agent (IBA)

7	Hemostatics (Antihemorrhagics)IBA 05/2024 - 09/2015
6	Glycoproteins (Glycoprotein)IBA 05/2024 - 01/2020
6	FibrinIBA 01/2023 - 07/2015
5	Thrombin FDA Link 11/2023 - 06/2013
5	IntegrinsIBA 07/2023 - 07/2013
4	Fibrinogen (Factor I)FDA Link 10/2023 - 10/2020
4	CollagenIBA 01/2023 - 06/2013
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2023 - 02/2023
3	Clopidogrel (Plavix)FDA Link 06/2023 - 05/2016
2	Thrombopoietin (c-mpl Ligand)IBA 03/2024 - 02/2015
2	Immunoglobulin Fab FragmentsIBA 11/2023 - 01/2020
2	Platelet Membrane Glycoprotein IIbIBA 11/2023 - 05/2016
2	glenzocimabIBA 11/2023 - 01/2020
2	Tirofiban (Aggrastat)FDA Link 06/2023 - 02/2023
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 06/2023 - 01/2018
2	ferric chlorideIBA 05/2022 - 02/2015
2	Fibronectins (Fibronectin)IBA 05/2022 - 11/2015
2	Fibrillar CollagensIBA 01/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2011
1	TicagrelorIBA 11/2023
1	Monoclonal AntibodiesIBA 11/2023
1	amotosalenIBA 10/2023
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 06/2023
1	Heparin (Liquaemin)FDA LinkGeneric 02/2023
1	estropipate (Ogen)FDA LinkGeneric 01/2023
1	LipopolysaccharidesIBA 05/2022
1	Explosive Agents (Explosives)IBA 10/2020
1	Blood Proteins (Serum Proteins)IBA 10/2020
1	Type C PhospholipasesIBA 01/2020
1	PlasticsIBA 01/2020
1	src-Family KinasesIBA 01/2020
1	Tyrosine (L-Tyrosine)FDA Link 01/2020
1	Saline SolutionIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2018
1	Eptifibatide (Integrilin)FDA Link 05/2016
1	2- iodo- N(6)- methyl- (N)- methanocarba- 2'- deoxyadenosine- 3',5'- bisphosphateIBA 05/2016
1	Purinergic P2 Receptors (ADP Receptor)IBA 05/2016
1	HirudinsIBA 05/2016
1	Toll-Like Receptor 4IBA 11/2015
1	Apolipoproteins E (ApoE)IBA 02/2015
1	AnticoagulantsIBA 02/2015
1	Fondaparinux (Arixtra)FDA Link 02/2015
1	EP 217609IBA 02/2015
1	FIIaIBA 02/2015
1	Cre recombinaseIBA 02/2015
1	N(alpha)- (2- naphthylsulfonylglycyl)- 4- amidinophenylalanine piperidide (NAPAP)IBA 02/2015
1	TenascinIBA 01/2011

Therapy/Procedure

3	Therapeutics 11/2023 - 01/2020
3	Stents 06/2023 - 09/2017
2	Thrombectomy 06/2023 - 02/2023
2	Lasers (Laser) 05/2022 - 06/2013
1	Carotid Endarterectomy 11/2023
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2023
1	Punctures 01/2022
1	Percutaneous Coronary Intervention 09/2017
1	Surgical Instruments (Clip) 06/2013